Annual Report

Read the Annual Report

Novo Nordisk Annual Report 2015 accounts for our financial, social and environmental performance during the year in one integrated report.

Featured articles from the Annual Report 2015

AR cities diabetes picture

Why do so many people
in cities get diabetes?

What makes people in cities vulnerable to diabetes, and how can we prevent people from
getting diabetes in the first place?
Read more


AR obesity care image

Obesity care – building the market from scratch

How do you market a treatment
for a disease that many doctors don’t even acknowledge?
Read more


AR GLP-1 article image

GLP-1 – Small protein, big potential

Glucagon-like peptide-1 (GLP-1) analogues are a relatively new therapy for  diabetes – but Novo Nordisk has been researching them for almost a quarter of a century.
Read more


Additional reporting

AR Form 20-F image

Form 20-F

Annual reporting requirement by the US Securities and Exchange Commission (SEC) for foreign private issuers with equity shares listed on exchanges in the United States.

AR Corporate governance report image

Corporate Governance Report

Requirement according to the Danish Financial Statements Act. Reporting of compliance with Danish Corporate Governance Recommendations.

AR UN Global Compact image

UN Global Compact Report

Voluntary Communication on Progress reporting in the form of the United Nations and its 10 principles in the areas of human rights, labour rights, Environment and anti-corruption.

Other resources